Amperos Health Raises $16M Series A to Automate Insurance Denial Recovery for Healthcare Providers
Revenue in healthcare doesn’t disappear. It gets stuck, delayed, denied, buried under layers of friction that look administrative until they start hitting like financial gravity. Providers do the work, deliver the care, and then wait… and wait… and then hire more people just to chase what was already earned. Amperos Health stepped into that gap and built for the part everyone hates but nobody can ignore.
The New York City crew led by Michal Miernowski (Co-Founder & CEO) and Wilson Wang (Co-Founder & CTO), alongside Alvin Wu (Co-Founder & CPO), has locked in $16M in Series A funding, with Bessemer Venture Partners leading the round and Uncork Capital and Neo running it back. That brings them to over $20.2M raised since 10/2023, which in startup years is basically going from dial-up to fiber before most teams finish their first pitch deck.
But the real story is not the round. It is the receipts. Over 3,000 clinics. More than 500,000 claims processed. Nearly $700M in revenue recovered annually. That is not theory. That is money providers thought was gone, now back where it belongs. Amperos Health is recovering 22% more per claim at up to 50% lower cost, while most legacy vendors are still treating denial management like it is 2009 with better fonts.
The product at the center of this is Amanda, their AI biller. Not a chatbot playing dress-up, but a system that works the entire denial lifecycle. Calls payers. Navigates portals. Submits corrected claims. Attaches records. Pushes appeals through to resolution. All day, all night, no coffee breaks, no turnover problem. Meanwhile, 63% of RCM teams are understaffed and burning out at a 32% turnover rate. The math was never mathing until now.
What stands out is how Amperos Health did not try to wedge intelligence into one step of the workflow. They went end to end. Voice automation meets browser agents meets decisioning systems, all stitched together to act like a seasoned biller who never forgets, never slows down, and never lets a claim die quietly in a queue.
Bessemer Venture Partners saw it. Uncork Capital saw it early. Neo stayed in the pocket. That kind of investor alignment usually shows up when a company is not just solving a problem, but exposing how broken the system was to begin with.
For providers, this is less about shiny tech and more about survival. Margins are tight, denial rates keep climbing, and chasing payments has become its own full-time sport. Amperos Health is turning that grind into a system, and a system into leverage. And if you listen closely, beneath the funding headlines and the noise, you can hear something else. Not hype. Not noise. Just the sound of money that was already earned finally making its way home.
